Status:

COMPLETED

Effect of Octreotide on the Colonic Motility in Pediatric Patients

Lead Sponsor:

Indiana University

Conditions:

Colonic Motility Index

Constipation

Eligibility:

All Genders

1-18 years

Phase:

PHASE4

Brief Summary

The research study is designed to test how a medication called octreotide affects the motility (contraction or squeezing) of the colon (large intestine). Investigators are investigating whether octreo...

Detailed Description

As mentioned above.

Eligibility Criteria

Inclusion

  • Male or female and undergoing colonic manometry for a routinely accepted indication including: evaluation of chronic constipation, unexplained abdominal distension (Should have had previous diagnostic work up), recurrent fecal impaction, post Hirschsprung's disease repair, chronic intestinal pseudo-obstruction, or suspected colonic dysmotility of any other cause.
  • Children aged 12 months or older who are undergoing colonic motility under the supervision of Dr. Joseph Croffie at Riley Hospital.
  • In the investigator's judgment, parent(s)/guardian(s) is mentally competent to provide informed consent to participate in the study.

Exclusion

  • • Subjects with known or suspected allergy to octreotide.
  • Subjects with known prolonged corrected QT interval (QTc) Syndrome or highest risk QTc-Prolonging Agents (including mifepristone).
  • Subjects with known history of ventricular arrhythmia.
  • Subjects with history of any organ transplant who are taking cyclosporine at the time of the motility study.
  • Subjects with history of small bowel transplant.
  • Subjects less than 12 months old.
  • Subjects with severe renal impairment
  • Subjects with severe hepatic impairment
  • Subjects taking bromocriptine, insulin, oral hypoglycemic agents, beta blockers, calcium channel blockers, quinidine, terfenadine, pimozide, sildenafil, tadalafil, and any agents to control fluid and electrolyte imbalance

Key Trial Info

Start Date :

August 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2014

Estimated Enrollment :

13 Patients enrolled

Trial Details

Trial ID

NCT01917773

Start Date

August 1 2013

End Date

June 1 2014

Last Update

December 21 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Motility Laboratory, Division of Pediatric Gastroenterology, Hepatology and Nutrition at the James Whitcomb Riley Hospital for Children,

Indianapolis, Indiana, United States, 46202